Similar Items: Trispecific antibodies: is more always better? Advances and boundaries
- Technology advancements in antibody purification [Corrigendum]
- Is more always better? Measuring the quality of ranking data through information entropy
- Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives
- Diagnostic antibodies at an inflection point: From discovery platforms to design‐oriented engineering
- Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
- Existence of solutions to a noncontractive caputo fractional delay integral boundary value problem